Inventor
MA VU VAN
US23 patents
⚠️ This page may combine multiple inventors who share the name “MA VU VAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
17 patentsUS11090304B2Aug 17, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC33 citations94
US9611261B2Apr 4, 2017
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC25 citations94
US9085576B2Jul 21, 2015
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC31 citations94
US11053226B2Jul 6, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC25 citations91
US12083121B2Sep 10, 2024
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC7 citations85
US11766436B2Sep 26, 2023
KRAS G12C inhibitors and methods of using the same
AMGEN INC11 citations85
US11285156B2Mar 29, 2022
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC16 citations85
US9096527B2Aug 4, 2015
TRPM8 antagonists and their use in treatments
AMGEN INC5 citations72
US12440491B2Oct 14, 2025
KRAS G12C inhibitors and methods of using the same
AMGEN INC1 citations64
US7439360B2Oct 21, 2008
Vanilloid receptor ligands and their use in treatments
AMGEN INC3 citations62
US8026241B2Sep 27, 2011
Vanilloid receptor ligands and their use in treatments
AMGEN INC3 citations60
US7582761B2Sep 1, 2009
Vanilloid receptor ligands and their use in treatments
AMGEN INC2 citations60
US7514438B2Apr 7, 2009
Melanin concentrating hormone receptor antagonist
AMGEN INC2 citations58
US11279712B2Mar 22, 2022
Macrocyclic compounds that inhibit MCL-1 protein
AMGEN INC0 citations51
US9550762B2Jan 24, 2017
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC1 citations51
US12473289B2Nov 18, 2025
Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
AMGEN INC0 citations46
US8952009B2Feb 10, 2015
Chroman derivatives as TRPM8 inhibitors
AMGEN INC0 citations41